Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Harvard Apparatus Regenerative Technology, Inc.HRGN · Entity 7501 | Director | June 27, 2025 | July 01, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Harvard Apparatus Regenerative Technology, Inc.
Report date June 27, 2025 · Filed July 01, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.60 · Expires 2035-06-27 | Direct | 18,590 |
Reported balance
After 2025-06-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-06-27 · Grant · Acquired 18,590 · Balance 18,590 F1: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 27, 2025, December 27, 2025, March 27, 2026 and June 27, 2026. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.60 · Expires 2035-06-27 | Direct | 15,227 |
Reported balance
After 2025-06-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-06-27 · Grant · Acquired 15,227 · Balance 15,227 F2: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2025, September 30, 2025 and December 31, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 27, 2025, December 27, 2025, March 27, 2026 and June 27, 2026.
F2: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2025, September 30, 2025 and December 31, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 27, 2025 Filed Jul 1, 2025 18:00 UTC | Harvard Apparatus Regenerative Technology, Inc. HRGN · Entity 7501 | GrantStock Option (right to buy) · Derivative | 15,227 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001437749-25-021707 · rdgdoc.xml · derivative · entry 2 Sanchez Herman · CIK 0001843559 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,227 Underlying: Common Stock, par value $0.01 per share · 15,227 shares Expires 2035-06-27 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2025, September 30, 2025 and December 31, 2025. Read SEC document |
| June 27, 2025 Filed Jul 1, 2025 18:00 UTC | Harvard Apparatus Regenerative Technology, Inc. HRGN · Entity 7501 | GrantStock Option (right to buy) · Derivative | 18,590 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001437749-25-021707 · rdgdoc.xml · derivative · entry 1 Sanchez Herman · CIK 0001843559 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,590 Underlying: Common Stock, par value $0.01 per share · 18,590 shares Expires 2035-06-27 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 27, 2025, December 27, 2025, March 27, 2026 and June 27, 2026. Read SEC document |
| June 27, 2024 Filed Jul 15, 2024 15:10 UTC | Harvard Apparatus Regenerative Technology, Inc. HRGN · Entity 7501 | GrantStock Option (right to buy) · Derivative | 8,215 | $0.00 Strike: $2.92 | $0.00 |
DisclosureSEC source: 0001493152-24-027253 · ownership.xml · derivative · entry 2 Sanchez Herman · CIK 0001843559 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,215 Underlying: Common Stock, par value $0.01 per share · 8,215 shares Expires 2034-06-27 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2024, September 30, 2024 and December 31, 2024. Read SEC document |
| June 27, 2024 Filed Jul 15, 2024 15:10 UTC | Harvard Apparatus Regenerative Technology, Inc. HRGN · Entity 7501 | GrantStock Option (right to buy) · Derivative | 10,204 | $0.00 Strike: $2.92 | $0.00 |
DisclosureSEC source: 0001493152-24-027253 · ownership.xml · derivative · entry 1 Sanchez Herman · CIK 0001843559 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,204 Underlying: Common Stock, par value $0.01 per share · 10,204 shares Expires 2034-06-27 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 27, 2024, December 27, 2024, March 27, 2025 and June 27, 2025. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 20:00 UTC | Harvard Apparatus Regenerative Technology, Inc. HRGN · Entity 7501 | GrantStock Option (right to buy) · Derivative | 5,819 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001493152-23-025856 · ownership.xml · derivative · entry 2 Sanchez Herman · CIK 0001843559 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,819 Underlying: Common Stock, par value $0.01 per share · 5,819 shares Expires 2033-07-26 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, September 30, 2023, December 31, 2023 and March 31, 2024. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 20:00 UTC | Harvard Apparatus Regenerative Technology, Inc. HRGN · Entity 7501 | GrantStock Option (right to buy) · Derivative | 7,269 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001493152-23-025856 · ownership.xml · derivative · entry 1 Sanchez Herman · CIK 0001843559 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,269 Underlying: Common Stock, par value $0.01 per share · 7,269 shares Expires 2033-07-26 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on October 26, 2023, January 26, 2024, April 26, 2024 and July 26, 2024. Read SEC document |
| June 29, 2022 Filed Jul 1, 2022 21:54 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantStock Option (right to buy) · Derivative | 5,016 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001104659-22-076933 · tm2220305-1_4seq1.xml · derivative · entry 2 Sanchez Herman · CIK 0001843559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,016 Underlying: Common Stock, par value $0.01 per share · 5,016 shares Expires 2032-06-09 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2022, September 30, 2022 and December 31, 2022. Read SEC document |
| June 29, 2022 Filed Jul 1, 2022 21:54 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantStock Option (right to buy) · Derivative | 6,241 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001104659-22-076933 · tm2220305-1_4seq1.xml · derivative · entry 1 Sanchez Herman · CIK 0001843559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,241 Underlying: Common Stock, par value $0.01 per share · 6,241 shares Expires 2032-06-29 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 29, 2022, December 29, 2022, March 29, 2023 and June 29, 2023. Read SEC document |
| July 01, 2021 Filed Nov 11, 2021 01:37 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantStock Option (right to buy) · Derivative | 18,035 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001104659-21-137163 · tm2132445-5_4seq1.xml · derivative · entry 2 Sanchez Herman · CIK 0001843559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,535 Underlying: Common Stock, par value $0.01 per share · 18,035 shares Expires 2031-07-01 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, October 1, 2021, January 1, 2022 and April 1, 2022. Read SEC document |
| July 01, 2021 Filed Nov 11, 2021 01:37 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001104659-21-137163 · tm2132445-5_4seq1.xml · derivative · entry 1 Sanchez Herman · CIK 0001843559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock, par value $0.01 per share · 22,500 shares Expires 2031-07-01 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on October 1, 2021, January 1, 2022, April 1, 2022 and July 1, 2022. Read SEC document |
| January 26, 2021 Filed Feb 1, 2021 21:39 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantOption (right to buy) · Derivative | 16,413 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001104659-21-010237 · tm214887d2_form4.xml · derivative · entry 1 Sanchez Herman · CIK 0001843559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,413 Underlying: Common Stock · 16,413 shares Expires 2031-01-26 F1 · derivative.exercise_date: Stock Option represents the initial equity grant to the Reporting Person upon appointment as a non-employee director of the Issuer, and will vest in four equal installments on April 26, 2021, July 26, 2021, October 26, 2021, and January 26, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.